Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
7.66
-0.08 (-1.03%)
Jul 25, 2025, 2:45 PM CST

SHE:002349 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
Operating Revenue
1,3851,3881,4961,5501,3361,256
Upgrade
Other Revenue
13.6313.6315.4122.5821.4125.31
Upgrade
1,3981,4021,5121,5731,3581,281
Upgrade
Revenue Growth (YoY)
-4.38%-7.25%-3.90%15.85%5.97%10.71%
Upgrade
Cost of Revenue
714.07719.73781.18847.06739.21695.09
Upgrade
Gross Profit
684.42682.36730.58726618.66586.27
Upgrade
Selling, General & Admin
374.17366.72346.78401.01352.64302.35
Upgrade
Research & Development
55.1861.7964.6286.9874.7652.05
Upgrade
Other Operating Expenses
20.8417.4817.7722.3920.1719.71
Upgrade
Operating Expenses
453.64449.36431.89514.64462.16372.54
Upgrade
Operating Income
230.78233298.69211.36156.51213.73
Upgrade
Interest Expense
-0.84-1.34-2.57-6.79-12.94-19.65
Upgrade
Interest & Investment Income
43.7848.3823.8739.7114.1623.27
Upgrade
Currency Exchange Gain (Loss)
2.342.342.356.86-1.48-6.19
Upgrade
Other Non Operating Income (Expenses)
-1.26-0.30.43-1.241.45-1.58
Upgrade
EBT Excluding Unusual Items
274.8282.09322.76249.9157.7209.58
Upgrade
Impairment of Goodwill
------5.56
Upgrade
Gain (Loss) on Sale of Investments
1.733.826.834.9931.44-3.52
Upgrade
Gain (Loss) on Sale of Assets
-0.18-0.2-0.09-0.06-0.583.36
Upgrade
Asset Writedown
-6.21-2.13-4.52-16.96-16.7-148.15
Upgrade
Other Unusual Items
10.819.754.7112.347.038.04
Upgrade
Pretax Income
280.96293.32329.7250.21178.8963.74
Upgrade
Income Tax Expense
43.9645.8553.2337.9238.9335.82
Upgrade
Earnings From Continuing Operations
237247.47276.47212.29139.9627.93
Upgrade
Minority Interest in Earnings
-33.21-34.81-28.77-0.0620.7483.07
Upgrade
Net Income
203.79212.65247.7212.23160.7110.99
Upgrade
Net Income to Common
203.79212.65247.7212.23160.7110.99
Upgrade
Net Income Growth
-11.82%-14.15%16.71%32.06%44.79%-
Upgrade
Shares Outstanding (Basic)
814814814814814814
Upgrade
Shares Outstanding (Diluted)
814814814814814814
Upgrade
Shares Change (YoY)
-0.01%-0.01%0.02%-0.00%-0.03%0.03%
Upgrade
EPS (Basic)
0.250.260.300.260.200.14
Upgrade
EPS (Diluted)
0.250.260.300.260.200.14
Upgrade
EPS Growth
-11.81%-14.13%16.69%32.07%44.83%-
Upgrade
Free Cash Flow
319.53280.1262.93296.8225.02209.75
Upgrade
Free Cash Flow Per Share
0.390.340.320.360.280.26
Upgrade
Dividend Per Share
0.0800.0800.0920.0800.0600.041
Upgrade
Dividend Growth
-13.04%-13.04%15.00%33.33%46.34%-
Upgrade
Gross Margin
48.94%48.67%48.33%46.15%45.56%45.75%
Upgrade
Operating Margin
16.50%16.62%19.76%13.44%11.53%16.68%
Upgrade
Profit Margin
14.57%15.17%16.38%13.49%11.83%8.66%
Upgrade
Free Cash Flow Margin
22.85%19.98%17.39%18.87%16.57%16.37%
Upgrade
EBITDA
303.4307.95382.89319.43257.8297.72
Upgrade
EBITDA Margin
21.70%21.96%25.33%20.31%18.99%23.23%
Upgrade
D&A For EBITDA
72.6374.9484.21108.07101.2983.99
Upgrade
EBIT
230.78233298.69211.36156.51213.73
Upgrade
EBIT Margin
16.50%16.62%19.76%13.44%11.53%16.68%
Upgrade
Effective Tax Rate
15.65%15.63%16.14%15.16%21.76%56.19%
Upgrade
Revenue as Reported
1,3981,4021,5121,5731,3581,281
Upgrade
Advertising Expenses
-13.6913.657.2711.617.18
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.